ID

32219

Description

Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT01012830

Lien

https://clinicaltrials.gov/show/NCT01012830

Mots-clés

Versions (1)
  1. 23/10/2018 23/10/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

23 octobre 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Schizophrenia NCT01012830

Anglais

Eligibility Schizophrenia NCT01012830

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. age 19-59
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
2. diagnosis of schizophrenia by mini
Description

Schizophrenia Mini-mental state examination

Type de données

boolean

Alias
UMLS CUI [1,1]
C0036341
UMLS CUI [1,2]
C0451306
3. cognition score 1 standard deviation below published norms in controls
Description

Cognitive Assessment Score

Type de données

boolean

Alias
UMLS CUI [1,1]
C0870300
UMLS CUI [1,2]
C0449820
4. clinically stable for 12 weeks i.e. on the same antipsychotic(s) for 8 weeks and stable dose for at least 4 weeks
Description

Clinical status Stable | Antipsychotic Agent Dose Stable

Type de données

boolean

Alias
UMLS CUI [1,1]
C0449440
UMLS CUI [1,2]
C0205360
UMLS CUI [2,1]
C0040615
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205360
5. have no more than moderate severity rating on hallucinations, delusions formal thought disorder (bprs), negative symptoms (panss_n)
Description

Hallucinations Moderate BPRS | Delusions Moderate BPRS | Disorder of form of thought Moderate BPRS | PANSS Symptoms Negative

Type de données

boolean

Alias
UMLS CUI [1,1]
C0018524
UMLS CUI [1,2]
C0205081
UMLS CUI [1,3]
C0029941
UMLS CUI [2,1]
C0011253
UMLS CUI [2,2]
C0205081
UMLS CUI [2,3]
C0029941
UMLS CUI [3,1]
C0233636
UMLS CUI [3,2]
C0205081
UMLS CUI [3,3]
C0029941
UMLS CUI [4,1]
C4086747
UMLS CUI [4,2]
C1457887
UMLS CUI [4,3]
C1513916
6. minimal eps (simpson-angus <6)
Description

Extrapyramidal symptoms Minimal | Rating scale Extrapyramidal tract Side effects

Type de données

boolean

Alias
UMLS CUI [1,1]
C0234133
UMLS CUI [1,2]
C0547040
UMLS CUI [2,1]
C0681889
UMLS CUI [2,2]
C0015372
UMLS CUI [2,3]
C0879626
7. minimal depression (calgary <10)
Description

Minimal depression | Depression scale Schizophrenia

Type de données

boolean

Alias
UMLS CUI [1]
C4305327
UMLS CUI [2,1]
C0679604
UMLS CUI [2,2]
C0036341
8. stable dose of other psychotropics (2 months)
Description

Psychotropic Drugs Dose Stable

Type de données

boolean

Alias
UMLS CUI [1,1]
C0033978
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
9. not pregnant.
Description

Pregnancy Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0332197
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. history of active peptic ulcer disease within 1 year of screening
Description

Peptic Ulcer Disease length

Type de données

boolean

Alias
UMLS CUI [1,1]
C0030920
UMLS CUI [1,2]
C0872146
2. clinically significant cardiac arrhythmia
Description

Cardiac Arrhythmia

Type de données

boolean

Alias
UMLS CUI [1]
C0003811
3. resting pulse less than 50
Description

Pulse Rate At rest

Type de données

boolean

Alias
UMLS CUI [1,1]
C0232117
UMLS CUI [1,2]
C0443144
4. active cancer (skin tumors other than melanoma are not excluded)
Description

Malignant Neoplasms | Exception Skin carcinoma

Type de données

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0699893
5. history of clinically significant stroke
Description

Cerebrovascular accident

Type de données

boolean

Alias
UMLS CUI [1]
C0038454
6. current evidence or history in the past 2 years of epilepsy, focal brain lesion
Description

Epilepsy | Lesion of brain Focal

Type de données

boolean

Alias
UMLS CUI [1]
C0014544
UMLS CUI [2,1]
C0221505
UMLS CUI [2,2]
C0205234
7. start of cholinesterase inhibitors/ cognitive enhancers (galantamine, rivastigmine, donepezil, vitamin e and memantine) within 2 months of screening, 8. use of medications with significant central nervous system anticholinergic activity within 2 months of screening.
Description

Cholinesterase Inhibitors | Nootropic Agents | Galantamine | rivastigmine | donepezil | Vitamin E | Memantine | Anticholinergic Agents

Type de données

boolean

Alias
UMLS CUI [1]
C0008425
UMLS CUI [2]
C0242913
UMLS CUI [3]
C0016967
UMLS CUI [4]
C0649350
UMLS CUI [5]
C0527316
UMLS CUI [6]
C0042874
UMLS CUI [7]
C0025242
UMLS CUI [8]
C0242896
Retour au début de la page

Similar models

Eligibility Schizophrenia NCT01012830

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
1. age 19-59
boolean
C0001779 (UMLS CUI [1])
Schizophrenia Mini-mental state examination
Item
2. diagnosis of schizophrenia by mini
boolean
C0036341 (UMLS CUI [1,1])
C0451306 (UMLS CUI [1,2])
Cognitive Assessment Score
Item
3. cognition score 1 standard deviation below published norms in controls
boolean
C0870300 (UMLS CUI [1,1])
C0449820 (UMLS CUI [1,2])
Clinical status Stable | Antipsychotic Agent Dose Stable
Item
4. clinically stable for 12 weeks i.e. on the same antipsychotic(s) for 8 weeks and stable dose for at least 4 weeks
boolean
C0449440 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0040615 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
Hallucinations Moderate BPRS | Delusions Moderate BPRS | Disorder of form of thought Moderate BPRS | PANSS Symptoms Negative
Item
5. have no more than moderate severity rating on hallucinations, delusions formal thought disorder (bprs), negative symptoms (panss_n)
boolean
C0018524 (UMLS CUI [1,1])
C0205081 (UMLS CUI [1,2])
C0029941 (UMLS CUI [1,3])
C0011253 (UMLS CUI [2,1])
C0205081 (UMLS CUI [2,2])
C0029941 (UMLS CUI [2,3])
C0233636 (UMLS CUI [3,1])
C0205081 (UMLS CUI [3,2])
C0029941 (UMLS CUI [3,3])
C4086747 (UMLS CUI [4,1])
C1457887 (UMLS CUI [4,2])
C1513916 (UMLS CUI [4,3])
Extrapyramidal symptoms Minimal | Rating scale Extrapyramidal tract Side effects
Item
6. minimal eps (simpson-angus <6)
boolean
C0234133 (UMLS CUI [1,1])
C0547040 (UMLS CUI [1,2])
C0681889 (UMLS CUI [2,1])
C0015372 (UMLS CUI [2,2])
C0879626 (UMLS CUI [2,3])
Minimal depression | Depression scale Schizophrenia
Item
7. minimal depression (calgary <10)
boolean
C4305327 (UMLS CUI [1])
C0679604 (UMLS CUI [2,1])
C0036341 (UMLS CUI [2,2])
Psychotropic Drugs Dose Stable
Item
8. stable dose of other psychotropics (2 months)
boolean
C0033978 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
Pregnancy Absent
Item
9. not pregnant.
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Peptic Ulcer Disease length
Item
1. history of active peptic ulcer disease within 1 year of screening
boolean
C0030920 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Cardiac Arrhythmia
Item
2. clinically significant cardiac arrhythmia
boolean
C0003811 (UMLS CUI [1])
Pulse Rate At rest
Item
3. resting pulse less than 50
boolean
C0232117 (UMLS CUI [1,1])
C0443144 (UMLS CUI [1,2])
Malignant Neoplasms | Exception Skin carcinoma
Item
4. active cancer (skin tumors other than melanoma are not excluded)
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
Cerebrovascular accident
Item
5. history of clinically significant stroke
boolean
C0038454 (UMLS CUI [1])
Epilepsy | Lesion of brain Focal
Item
6. current evidence or history in the past 2 years of epilepsy, focal brain lesion
boolean
C0014544 (UMLS CUI [1])
C0221505 (UMLS CUI [2,1])
C0205234 (UMLS CUI [2,2])
Cholinesterase Inhibitors | Nootropic Agents | Galantamine | rivastigmine | donepezil | Vitamin E | Memantine | Anticholinergic Agents
Item
7. start of cholinesterase inhibitors/ cognitive enhancers (galantamine, rivastigmine, donepezil, vitamin e and memantine) within 2 months of screening, 8. use of medications with significant central nervous system anticholinergic activity within 2 months of screening.
boolean
C0008425 (UMLS CUI [1])
C0242913 (UMLS CUI [2])
C0016967 (UMLS CUI [3])
C0649350 (UMLS CUI [4])
C0527316 (UMLS CUI [5])
C0042874 (UMLS CUI [6])
C0025242 (UMLS CUI [7])
C0242896 (UMLS CUI [8])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial